Literature DB >> 10574047

[Surveillance of hepatitis A by molecular epidemiologic studies].

K Stene-Johansen1, K Skaug, H Blystad.   

Abstract

Hepatitis A virus was studied by molecular epidemiology in connection with an outbreak of hepatitis A associated with intravenous drug users (IVDU) in Norway. Hepatitis A virus was characterised by sequencing 114 of 1,242 notified cases of hepatitis A from January 1995 to July 1998. One hepatitis A variant (IVDU variant I) was detected among IVDU during an outbreak of hepatitis A, as well as among 19 out of 49 cases with no apparent association to this outbreak. During the autumn of 1997, a new variant (IVDU variant II) was detected in the IVDU communities. Genotyping of virus from imported cases associated with travel to endemic regions, revealed that they were distinct from the two other IVDU variants. Hepatitis A has disseminated among IVDU over years; this indicates that hepatitis A is endemic in these communities. At the turn of the year 1997/98, there was a smaller outbreak of hepatitis A among homosexual men in Oslo, distinguished by genotyping from the outbreaks in the IVDU communities. By molecular epidemiology we have been able to identify individual outbreaks of hepatitis A and distinguish them from the IVDU outbreak.

Entities:  

Mesh:

Year:  1999        PMID: 10574047

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  2 in total

1.  Genetic analysis of hepatitis A virus strains that induced epidemics in Korea during 2007-2009.

Authors:  Hyeokjin Lee; Hyesook Jeong; Heasun Yun; Kisang Kim; Jong-Hyun Kim; Jai Myung Yang; Doo-Sung Cheon
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Molecular characterization of hepatitis A virus from children hospitalized at a tertiary care centre in northwest India.

Authors:  Bharti Malhotra; Anu Kanwar; P V Janardhan Reddy; Aradhana Chauhan; Jitendra Tiwari; Shipra Bhargava; H N Verma
Journal:  Indian J Med Res       Date:  2018-05       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.